Depression pathogenesis and treatment

What can we learn from blood mRNA expression?

Nilay Hepgul, Annamaria Cattaneo, Patricia A. Zunszain, Carmine M. Pariante

Research output: Contribution to journalArticle

62 Citations (Scopus)

Abstract

Alterations in several biological systems, including the neuroendocrine and immune systems, have been consistently demonstrated in patients with major depressive disorder. These alterations have been predominantly studied using easily accessible systems such as blood and saliva. In recent years there has been an increasing body of evidence supporting the use of peripheral blood gene expression to investigate the pathogenesis of depression, and to identify relevant biomarkers. In this paper we review the current literature on gene expression alterations in depression, focusing in particular on three important and interlinked biological domains: inflammation, glucocorticoid receptor functionality and neuroplasticity. We also briefly review the few existing transcriptomics studies. Our review summarizes data showing that patients with major depressive disorder exhibit an altered pattern of expression in several genes belonging to these three biological domains when compared with healthy controls. In particular, we show evidence for a pattern of 'state-related' gene expression changes that are normalized either by remission or by antidepressant treatment. Taken together, these findings highlight the use of peripheral blood gene expression as a clinically relevant biomarker approach.

Original languageEnglish
Article number28
JournalBMC Medicine
Volume11
Issue number1
DOIs
Publication statusPublished - Feb 5 2013

Fingerprint

Depression
Gene Expression
Messenger RNA
Major Depressive Disorder
Biomarkers
Neurosecretory Systems
Neuronal Plasticity
Glucocorticoid Receptors
Therapeutics
Saliva
Antidepressive Agents
Immune System
Inflammation
Genes

Keywords

  • depression
  • gene expression
  • glucocorticoid receptor
  • inflammation
  • microarray
  • mRNA
  • neuroplasticity
  • peripheral blood
  • transcriptomics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Depression pathogenesis and treatment : What can we learn from blood mRNA expression? / Hepgul, Nilay; Cattaneo, Annamaria; Zunszain, Patricia A.; Pariante, Carmine M.

In: BMC Medicine, Vol. 11, No. 1, 28, 05.02.2013.

Research output: Contribution to journalArticle

Hepgul, Nilay ; Cattaneo, Annamaria ; Zunszain, Patricia A. ; Pariante, Carmine M. / Depression pathogenesis and treatment : What can we learn from blood mRNA expression?. In: BMC Medicine. 2013 ; Vol. 11, No. 1.
@article{7308533c24e64d45ae7e940cce44625f,
title = "Depression pathogenesis and treatment: What can we learn from blood mRNA expression?",
abstract = "Alterations in several biological systems, including the neuroendocrine and immune systems, have been consistently demonstrated in patients with major depressive disorder. These alterations have been predominantly studied using easily accessible systems such as blood and saliva. In recent years there has been an increasing body of evidence supporting the use of peripheral blood gene expression to investigate the pathogenesis of depression, and to identify relevant biomarkers. In this paper we review the current literature on gene expression alterations in depression, focusing in particular on three important and interlinked biological domains: inflammation, glucocorticoid receptor functionality and neuroplasticity. We also briefly review the few existing transcriptomics studies. Our review summarizes data showing that patients with major depressive disorder exhibit an altered pattern of expression in several genes belonging to these three biological domains when compared with healthy controls. In particular, we show evidence for a pattern of 'state-related' gene expression changes that are normalized either by remission or by antidepressant treatment. Taken together, these findings highlight the use of peripheral blood gene expression as a clinically relevant biomarker approach.",
keywords = "depression, gene expression, glucocorticoid receptor, inflammation, microarray, mRNA, neuroplasticity, peripheral blood, transcriptomics",
author = "Nilay Hepgul and Annamaria Cattaneo and Zunszain, {Patricia A.} and Pariante, {Carmine M.}",
year = "2013",
month = "2",
day = "5",
doi = "10.1186/1741-7015-11-28",
language = "English",
volume = "11",
journal = "BMC Medicine",
issn = "1741-7015",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - Depression pathogenesis and treatment

T2 - What can we learn from blood mRNA expression?

AU - Hepgul, Nilay

AU - Cattaneo, Annamaria

AU - Zunszain, Patricia A.

AU - Pariante, Carmine M.

PY - 2013/2/5

Y1 - 2013/2/5

N2 - Alterations in several biological systems, including the neuroendocrine and immune systems, have been consistently demonstrated in patients with major depressive disorder. These alterations have been predominantly studied using easily accessible systems such as blood and saliva. In recent years there has been an increasing body of evidence supporting the use of peripheral blood gene expression to investigate the pathogenesis of depression, and to identify relevant biomarkers. In this paper we review the current literature on gene expression alterations in depression, focusing in particular on three important and interlinked biological domains: inflammation, glucocorticoid receptor functionality and neuroplasticity. We also briefly review the few existing transcriptomics studies. Our review summarizes data showing that patients with major depressive disorder exhibit an altered pattern of expression in several genes belonging to these three biological domains when compared with healthy controls. In particular, we show evidence for a pattern of 'state-related' gene expression changes that are normalized either by remission or by antidepressant treatment. Taken together, these findings highlight the use of peripheral blood gene expression as a clinically relevant biomarker approach.

AB - Alterations in several biological systems, including the neuroendocrine and immune systems, have been consistently demonstrated in patients with major depressive disorder. These alterations have been predominantly studied using easily accessible systems such as blood and saliva. In recent years there has been an increasing body of evidence supporting the use of peripheral blood gene expression to investigate the pathogenesis of depression, and to identify relevant biomarkers. In this paper we review the current literature on gene expression alterations in depression, focusing in particular on three important and interlinked biological domains: inflammation, glucocorticoid receptor functionality and neuroplasticity. We also briefly review the few existing transcriptomics studies. Our review summarizes data showing that patients with major depressive disorder exhibit an altered pattern of expression in several genes belonging to these three biological domains when compared with healthy controls. In particular, we show evidence for a pattern of 'state-related' gene expression changes that are normalized either by remission or by antidepressant treatment. Taken together, these findings highlight the use of peripheral blood gene expression as a clinically relevant biomarker approach.

KW - depression

KW - gene expression

KW - glucocorticoid receptor

KW - inflammation

KW - microarray

KW - mRNA

KW - neuroplasticity

KW - peripheral blood

KW - transcriptomics

UR - http://www.scopus.com/inward/record.url?scp=84873257915&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84873257915&partnerID=8YFLogxK

U2 - 10.1186/1741-7015-11-28

DO - 10.1186/1741-7015-11-28

M3 - Article

VL - 11

JO - BMC Medicine

JF - BMC Medicine

SN - 1741-7015

IS - 1

M1 - 28

ER -